Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Dahinden, C; Ingold, B; Wild, P; Boysen, G; Luu, V D; Montani, M; Kristiansen, G; Sulser, T; Bühlmann, P; Moch, H; Schraml, P (2010). Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer. Clinical Cancer Research, 16(1):88-98.

Balamurugan, K; Luu, V D; Kaufmann, M R; Hofmann, V S; Boysen, G; Barth, S; Bordoli, M R; Stiehl, D P; Moch, H; Schraml, P; Wenger, R H; Camenisch, G (2009). Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. Oncogene:1-12.

Boysen, G; Wollscheid, B; Bausch-Fluck, D; Schraml, P; Moch, H (2009). Identifizierung VHL-assoziierter Veränderungen im klarzelligen Nierenzellkarzinom : Anwendung von kombinierten Genom- und Expressionsanalysen. Der Pathologe, Suppl 2:188-192.

Luu, V D; Boysen, G; Struckmann, K; Casagrande, S; von Teichman, A; Wild, P J; Sulser, T; Schraml, P; Moch, H (2009). Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma. Clinical Cancer Research, 15(10):3297-3304.

Schraml, P; Frew, I J; Thoma, C R; Boysen, G; Struckmann, K; Krek, W; Moch, H (2008). Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia. Modern Pathology, 22(1):31-36.

Luu, V D; Fischer, B; von Teichman, A; Boysen, G; Mertz, K; Zimmermann, P; Moch, H; Schraml, P (2008). Von-Hippel-Lindau-Gen-Mutationstypen: Assoziation mit Genexpressionssignaturen in klarzelligen Nierenzellkarzinomen. Der Pathologe, 29(Suppl.):303-307.

This list was generated on Sat Oct 21 11:36:06 2017 CEST.